A61K31/055

AQUEOUS WOUND HEALING FORMULATION

The present invention relates to a water resistant wound cover with high comfort and good air permeability. In particular, the present invention relates to an aqueous wound healing formulation comprising a water-soluble or a water-dispersible polymeric material that does not sting when applied to a minor injury to the skin.

AQUEOUS WOUND HEALING FORMULATION

The present invention relates to a water resistant wound cover with high comfort and good air permeability. In particular, the present invention relates to an aqueous wound healing formulation comprising a water-soluble or a water-dispersible polymeric material that does not sting when applied to a minor injury to the skin.

Combination of carotenoids and epi-lutein
09849178 · 2017-12-26 · ·

The invention describes the preparation and use of carotenoid and epi-lutein compositions to treat various ocular diseases.

Combination of carotenoids and epi-lutein
09849178 · 2017-12-26 · ·

The invention describes the preparation and use of carotenoid and epi-lutein compositions to treat various ocular diseases.

Combination of carotenoids and epi-lutein
09849178 · 2017-12-26 · ·

The invention describes the preparation and use of carotenoid and epi-lutein compositions to treat various ocular diseases.

Method of treating TDP-43 proteinopathies using hexachlorophene

A method of treating TDP-43 proteinopathies such as Alzheimer's disease, amyotrophic lateral sclerosis, and fronto-temporal lobar dementia is presented herein. It was found that administering hexachlorophene to cells expressing endogenous TDP-43 or overexpressing wild-type TDP-43 reduced accumulation of TDP-43 in the cells.

Method of treating TDP-43 proteinopathies using hexachlorophene

A method of treating TDP-43 proteinopathies such as Alzheimer's disease, amyotrophic lateral sclerosis, and fronto-temporal lobar dementia is presented herein. It was found that administering hexachlorophene to cells expressing endogenous TDP-43 or overexpressing wild-type TDP-43 reduced accumulation of TDP-43 in the cells.

Oral antiseptic composition useful for treating oral mucositis
09801916 · 2017-10-31 ·

Antiseptic pharmaceutical composition useful for the treatment of painful lesions in oral mucosa, ulcerative and inflammatory lesions of different origin and the treatment and/or prevention of oral mucositis and stomatitis.

Oral antiseptic composition useful for treating oral mucositis
09801916 · 2017-10-31 ·

Antiseptic pharmaceutical composition useful for the treatment of painful lesions in oral mucosa, ulcerative and inflammatory lesions of different origin and the treatment and/or prevention of oral mucositis and stomatitis.

Oral antiseptic composition useful for treating oral mucositis
09801916 · 2017-10-31 ·

Antiseptic pharmaceutical composition useful for the treatment of painful lesions in oral mucosa, ulcerative and inflammatory lesions of different origin and the treatment and/or prevention of oral mucositis and stomatitis.